Brentuximab vedotin for the treatment of CD30+ lymphomas

Kelley V. Foyil, Nancy L. Bartlett

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Brentuximab vedotin for the treatment of CD30+ lymphomas'. Together they form a unique fingerprint.

Medicine & Life Sciences